Literature DB >> 6163827

The biochemical characterization of a cell surface antigen associated with acute lymphoblastic leukemia and lymphocyte precursors.

R A Newman, R Sutherland, M F Greaves.   

Abstract

The acute lymphoblastic leukemia- (ALL) associated membrane antigen is a single glycosylated polypeptide of approximate m.w. of 100,000 (gp100), containing no intrachain disulfide linkages. Approximately 50% of gp100 will bind to lentil lectin, whereas 100% will bind to the lectin from Ricinus communis. Both lentil-binding and lentil nonbinding forms of the antigen appear to be identical by 2-dimensional isoelectric focusing/SDS polyacrylamide gel electrophoresis and peptide mapping. Carbohydrate, although contributing approximately 20 to 25% of the m.w., appears not to be involved in the antigenic site of the ALL antigen as judged by precipitation of a molecule after tunicamycin treatment of cells or glycosidase digestion. Charge shift electrophoresis and labeling with the lipophilic nitrene reagent hexanoyl diiodo-N-(4-azido-2-nitrophenyl)-tyramine suggests that the cALL antigen is probably not an integral membrane protein; however, it remains tightly bound to the plasma membrane after subcellular fractionation. A glycoprotein of the same m.w. has been detected by immunoprecipitation on bone marrow cells of nonleukemic patients. serologic studies indicate that the cALL-associated antigen is found on the terminal transferase-positive lymphoid cells, and it therefore seems likely that the gp100 molecule is a normal gene products of lymphocyte precursors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163827

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

2.  Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein.

Authors:  M A Shipp; N E Richardson; P H Sayre; N R Brown; E L Masteller; L K Clayton; J Ritz; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

3.  Lineage-related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional gel electrophoresis.

Authors:  S M Hanash; L J Baier; L McCurry; S A Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  Two monoclonal antibodies raised against a Burkitt lymphoma cell line recognise different cell types within lymphoid follicles.

Authors:  L J Murray; S Dhut; L C Walker; M Rainey; J A Habeshaw
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

5.  Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea.

Authors:  T M Haqqi; D D Anthony; S Gupta; N Ahmad; M S Lee; G K Kumar; H Mukhtar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

6.  Characterization of HLA-DR antigens on leukaemic cells.

Authors:  R A Newman; M F Greaves
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

7.  Differentiation of C3b receptors on human lymphocytes, phagocytes, erythrocytes and renal glomerulus cells by monoclonal antibodies.

Authors:  M P Dierich; H H Mussel; O Scheiner; T Ehlen; R Burger; H Peters; M Schmitt; S Trepke; G Zimmer
Journal:  Immunology       Date:  1982-01       Impact factor: 7.397

8.  Presence of HLA-D/DR antigens on the membrane of breast tumour cells.

Authors:  D Bernard; J C Maurizis; F Rusé; J Chassagne; P Chollet; B Sauvezie; M de Latour; R Plagne
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

9.  Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.

Authors:  A T Look; S L Melvin; L K Brown; M E Dockter; P K Roberson; S B Murphy
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

10.  Characterization of immune complexes in acute lymphoblastic leukaemia.

Authors:  R C Williams; M H Duncan; K S Tung; E R Stinson; L C Walker; M F Greaves
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.